Table IIIa.
IAV | IBV | VRS | HMPV | PIV‐1 | PIV‐2 | PIV‐3 | PIV‐4 | ICV | HRhV/EnV | SARS‐CoV | HCoV‐OC43 | HCoV‐229E | HCoV‐HKU1 | HCoV‐NL63 | AdV | HBoV | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ILI patients | 0 | 3 (1.3) | 6 (2.6) | 2 (0.8) | 6 (2.6) | 3 (1.3) | 17 (7.3) | 0 | 1 (0.4) | 36 (15.4) | 0 | 10 (4.3) | 2 (0.8) | 2 (0.8) | 4 (1.7) | 3 (1.3) | 1 (0.4) | 83 (35.5) |
Asymptomatic individuals | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 (8.9) | 0 | 0 | 0 | 0 | 0 | 0 | 1 (1.1) | 9 (10) |